A Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

Last updated: January 30, 2025
Sponsor: Wake Forest University Health Sciences
Overall Status: Completed

Phase

N/A

Condition

Hair Loss

Alopecia

Treatment

Revian Red All LED cap

Clinical Study ID

NCT05759338
IRB00094234
  • Ages 18-65
  • Female

Study Summary

The purpose of this study is to determine if the Revian Red All LED cap shows potential to be an effective treatment for Central centrifugal cicatricial alopecia (CCCA) by recruiting hair follicles back to anagen growth or by improving inflammation. The primary outcome is to determine if hair loss regression is halted. Secondary outcomes include hair regrowth and alleviation of signs and symptoms of the disease.

Participants will be asked to use the Revian Red All LED cap once daily for a 10-minute treatment regimen which is the current androgenetic alopecia recommendation.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Women who are between the age of eighteen years and sixty-five years

  • Biopsy-proven diagnosis of CCCA Stage II-IV.

  • Must be on stable treatment without changes (on doxycycline, topical steroids,minoxidil and/or post 8 rounds of intralesional steroids) for at least 3 months

Exclusion

Exclusion Criteria:

  • Subjects with other forms of hair loss that is not CCCA

  • Prior treatment with light source for alopecia

  • Males are excluded from this study since the prevalence of CCCA in males is sosignificantly low that it is difficult to find cases in a clinical setting

Study Design

Total Participants: 100
Treatment Group(s): 1
Primary Treatment: Revian Red All LED cap
Phase:
Study Start date:
July 10, 2022
Estimated Completion Date:
June 19, 2024

Study Description

Subjects who are willing to participate in a novel treatment for Revian Red All LED cap will be enrolled in this study. The cap uses two wavelengths of light, 620 nm and 660 nm. A study cap will be provided for each subject. Subjects will use the cap once daily, 10-minute treatment regimen which is the current androgenetic alopecia recommendation. The subjects will use the cap for a total of 6 months. To use the cap, subjects will connect the Revian Red All LED cap to a Smart App on a mobile phone device using Bluetooth. Subjects can use the Smart App to set daily reminders to use the cap, track and log usage, and use the 10 minute timer. No additional information will be stored on the Smart App. Only subjects will have access to the Smart App located on their personal mobile phone device.

Standardized photos and trichoscopic photos before starting treatment and every 2 months for x 6 total months will be taken to assess hairline stabilization and potential for regrowth. A baseline photo and completion photo will also be taken with a visio device. This will help determine pigmentation of the present hairs throughout the study.

Prior to study enrollment, all participants will receive a detailed explanation of the purpose of the study and will undergo written informed consent. Clinical history of hair loss and history of prior treatment will be obtained by administering a standardized questionnaire to all subjects. Subjects will also fill out a questionnaire regarding symptoms of their hair loss at each visit. There will be 4 visits total (1 Pre-treatment visit and 3 Follow up visits).

Connect with a study center

  • Wake Forest University Health Sciences Department of Dermatology

    Winston-Salem, North Carolina 27157
    United States

    Site Not Available

  • Wake Forest University Health Sciences, Dermatology

    Winston-Salem, North Carolina 27157
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.